吸入性COPD药物的现实世界使用:好,坏,丑
1Department of Medicine, University of Chicago, Chicago, Illinois, United States
Chronic obstructive pulmonary diseases (Miami, Fla.)
|July 25, 2024
概括
患有慢性阻塞性肺病 (COPD) 的患者因滥用和成本而难以获得吸入器的有效性. 改善的教育和最近的成本策略为更好的症状管理和坚持提供了希望.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 管理严重依赖于吸入药物.
- 由于与用户相关的因素,吸入器设备的实际有效性往往不够理想.
- 主要障碍包括吸入器的滥用和与成本相关的不遵守.
研究的目的:
- 审查COPD吸入器治疗的当前有希望的方向.
- 识别吸入器使用和坚持的持续挑战和关键问题.
- 突出需要紧急关注的领域,以改善患者的治疗结果.
主要方法:
- 这是一个视角审查,综合现有研究和临床观察.
- 它研究了改进吸入器技术和解决成本障碍的策略.
- 该审查考虑了各种教育干预措施和医疗保健环境.
主要成果:
- 吸入器的滥用是限制治疗疗效的重要因素,尽管有可用的教育策略.
- 与成本相关的不遵守仍然是一个持续的挑战,尽管最近的发展显示出有希望.
- 几十年来,改善吸入器技术的进展一直很缓慢.
结论:
- 有效的吸入器技术和坚持对于COPD管理至关重要.
- 需要多方面的方法,包括加强教育和解决成本.
- 紧急关注这些关键问题可以改善COPD患者的治疗结果.
更多相关视频
相关概念视频
Inhaled Medications
248
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
248
COPD: Management Using Bronchodilators and Corticosteroids
193
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
193
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
389
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
389
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K


